200 related articles for article (PubMed ID: 20084455)
1. Cynomorium songaricum extracts functionally modulate transporters of gamma-aminobutyric acid and monoamine.
Zhao G; Wang J; Qin GW; Guo LH
Neurochem Res; 2010 Apr; 35(4):666-76. PubMed ID: 20084455
[TBL] [Abstract][Full Text] [Related]
2. Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.
Zhao G; Bi C; Qin GW; Guo LH
Exp Biol Med (Maywood); 2009 Aug; 234(8):976-85. PubMed ID: 19491370
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.
Zhao G; Jiang ZH; Zheng XW; Zang SY; Guo LH
Pharmacol Biochem Behav; 2008 Sep; 90(3):363-71. PubMed ID: 18485464
[TBL] [Abstract][Full Text] [Related]
4. Safflower extracts functionally regulate monoamine transporters.
Zhao G; Zheng XW; Gai Y; Chu WJ; Qin GW; Guo LH
J Ethnopharmacol; 2009 Jul; 124(1):116-24. PubMed ID: 19527825
[TBL] [Abstract][Full Text] [Related]
5. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
6. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
7. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
8. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
[TBL] [Abstract][Full Text] [Related]
10. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
11. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
12. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
13. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
14. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
Halberstadt AL; Brandt SD; Walther D; Baumann MH
Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
[TBL] [Abstract][Full Text] [Related]
15. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
[TBL] [Abstract][Full Text] [Related]
16. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
[TBL] [Abstract][Full Text] [Related]
17. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
[TBL] [Abstract][Full Text] [Related]
18. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
[TBL] [Abstract][Full Text] [Related]
19. Clobenpropit, a histamine H
Mena-Avila E; Márquez-Gómez R; Aquino-Miranda G; Nieto-Alamilla G; Arias-Montaño JA
Pharmacol Rep; 2018 Feb; 70(1):146-155. PubMed ID: 29414147
[TBL] [Abstract][Full Text] [Related]
20. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
Tellez R; Gómez-Víquez L; Meneses A
Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]